4.6 Article

Theoretical aspects on the use of single-time-point dosimetry for radionuclide therapy

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

A Novel Time-Activity Information-Sharing Approach Using Nonlinear Mixed Models for Patient-Specific Dosimetry with Reduced Imaging Time Points: Application in SPECT/CT After 177Lu-DOTATATE

Theresa P. Devasia et al.

Summary: The study compared a novel method based on statistical mixed models with previously proposed single-time-point methods for estimating kidney time-activity. Results showed that mixed models performed better in estimating kidney TIA, with lower bias, greater precision, and significantly fewer outliers.

JOURNAL OF NUCLEAR MEDICINE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies

Xinchi Hou et al.

Summary: The study analyzed two STP dosimetry methods and evaluated dose errors for different radiopharmaceuticals, finding that a lognormal distribution is more suitable for capturing effective half-life distributions. The STP methods showed promise for dosimetry of Lu-177-DOTATATE and kidney dosimetry, but may compromise accuracy for some radiopharmaceuticals.

JOURNAL OF NUCLEAR MEDICINE (2021)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Will SPECT/CT Cameras Soon Be Able to Display Absorbed Doses? Dosimetry from Single-Activity-Concentration Measurements

Heribert Haenscheid et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Personalized radiation dosimetry for PRRT-how many scans are really required?

Nanette Freedman et al.

EJNMMI PHYSICS (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points

Mattias Sandstrom et al.

EJNMMI PHYSICS (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Dose Mapping After Endoradiotherapy with Lu-177-DOTATATE/DOTATOC by a Single Measurement After 4 Days

Heribert Haenscheid et al.

JOURNAL OF NUCLEAR MEDICINE (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Technical Note: Single time point dose estimate for exponential clearance

Mark T. Madsen et al.

MEDICAL PHYSICS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations

Jonathan I. Gear et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Accuracy and reproducibility of simplified QSPECT dosimetry for personalized 177Lu-octreotate PRRT

Michela Del Prete et al.

EJNMMI PHYSICS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Feasibility of simplifying renal dosimetry in 177Lu peptide receptor radionuclide therapy

Anna Sundlov et al.

EJNMMI PHYSICS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Feasibility and accuracy of single time point imaging for renal dosimetry following 177Lu-DOTATATE (Lutate') therapy

Kathy P. Willowson et al.

EJNMMI PHYSICS (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

Anna Sundlov et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force

Caroline Stokke et al.

EJNMMI PHYSICS (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

Treatment of hyperthyroidism with radioiodine targeted activity: A comparison between two dosimetric methods

Ernesto Amato et al.

PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2016)

Article Engineering, Biomedical

Uncertainty propagation for SPECT/CT-based renal dosimetry in 177Lu peptide receptor radionuclide therapy

Johan Gustafsson et al.

PHYSICS IN MEDICINE AND BIOLOGY (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Thyroid Cancer: Radiation Safety Precautions in 131I Therapy Based on Actual Biokinetic Measurements

Bin Liu et al.

RADIOLOGY (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Dosimetry prior to I-131-therapy of benign thyroid disease

Heribert Haenscheid et al.

ZEITSCHRIFT FUR MEDIZINISCHE PHYSIK (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer

Walter Jentzen et al.

JOURNAL OF NUCLEAR MEDICINE (2008)

Article Oncology

Physical and chemical properties of radionuclide therapy

BW Wessels et al.

SEMINARS IN RADIATION ONCOLOGY (2000)